Dow IncNYSE: DOW
Materials · Commodity Chemicals
$40.39
-0.25%
Vol: 7.0M
Research Digest
Friday, May 1, 2026
Dow Inc reports $553M Q1 2026 net loss on volume disruptions; CEO succession announced
Dow Inc. reported Q1 2026 net loss of $553 million with net sales declining 6.1% YoY to $9.79 billion amid declining volumes and disruptions. Chief Operating Officer Karen Carter will succeed CEO Jim Fitterling effective July 1, 2026, marking significant leadership transition. Deutsche Bank raised price target to $40 from $38. Polyethylene markets show record sales and tight inventories. Stock recovered 4.0% on April 29 amid market volatility. Dividend of $0.35 approved (ex-date May 29).
Previous Market Intelligence
13 daysApr 30Dow Inc reports Q1 2026 net sales of $9.8B beating consensus; CEO transition announced with Karen Carter taking helm July 1.Positive▶
Dow Inc announced Q1 2026 results on April 23 with net sales of $9.8B, beating the $9.65B consensus estimate despite 6% YoY decline. Adjusted operating EPS of -$0.14 significantly beat the -$0.39 estimate, though GAAP loss per share was -$0.74. Operating EBITDA reached $873M with 3% volume growth. Karen Carter will become CEO on July 1, 2026, with Jim Fitterling transitioning to Executive Chair. The company declared a quarterly dividend of $0.35/share.
Apr 29Dow reports Q1 2026 net loss of $533M and announces CEO transition: Karen Carter becomes CEO in July, Fitterling moves to ChairMixed▶
Dow Inc. reported Q1 2026 results with sales of $9.794 billion and net loss of $533 million, down 7% in local prices with 2% volume decline driven by Middle East supply disruptions. COO Karen Carter will become CEO in July 2026, with Jim Fitterling transitioning to Executive Chair. Stock is up 8.6% year-to-date. Citigroup upgraded DOW to buy from neutral citing export supply constraints as a catalyst.
Apr 16Karen Carter named CEO effective July 1; company launches $2 billion cost reduction program targeting 4,500 job cuts.Mixed▶
DOW Inc announced Monday that Chief Operating Officer Karen S. Carter will become Chief Executive Officer effective July 1, 2026, while CEO Jim Fitterling transitions to executive chair. The company unveiled its Transform to Outperform program targeting at least $2 billion of near-term operating EBITDA uplift. The restructuring expects $1.1-1.5 billion in one-time costs including $600-800 million for severance affecting approximately 4,500 roles, with a phased timeline targeting $500 million in-year savings for 2026. Petrochemical supply shortages driven by Middle East tensions have boosted investor sentiment, though recent downgrades suggest analysts anticipate a challenging earnings report on April 23.
Apr 15Dow Inc falls 3.2% as investors reassess chemical pricing tailwinds; Q1 earnings April 23.Negative▶
Dow Inc. held its 2026 Annual Stockholder Meeting on April 9. The Board declared a $0.35 quarterly dividend (459th consecutive since 1912). On April 14, Dow announced a leadership transition causing a 1.2% pre-market decline. The stock fell 3.2% as investors questioned whether recent margin strength from geopolitical disruptions is sustainable. Q1 earnings are due April 23 with analyst projections of a $0.32 loss per share.
Apr 14Dow Inc received multiple analyst upgrades with price targets raised to $47-48 ahead of Q1 earnings on April 23.Positive▶
Dow Inc experienced analyst price target increases from RBC Capital ($47), Alembic Global upgraded to Overweight, and Citi raised target to $48 on April 8. Set to report Q1 earnings on April 23 with analyst expectations of a $0.32 loss per share. Stock has 67.1% year-to-date gain on geopolitical tailwinds.
Apr 13Dow announced 'Transform to Outperform' restructuring targeting $2B EBITDA uplift with $600-800M severance for 4,500 roles.Negative▶
DOW launched Transform to Outperform program targeting $2B near-term EBITDA uplift on top of prior $1B savings. Plan expects $1.1-1.5B one-time costs including severance for ~4,500 roles ($600-800M), phased: $500M 2026, $1.2B 2027, $300M 2028. Kyndryl expanded AI collaboration. Q1 2026 earnings April 23 with $0.32 EPS loss expected. RBC and Citi raised price targets to $47-48 from $40.
Apr 10Dow Inc upgraded to Overweight by Alembic Global amid chemical sector volatilityMixed▶
Alembic Global upgraded to Overweight with $48 target. Executing Transform to Outperform program targeting $2B EBITDA uplift. Earnings April 23.
Apr 9Dow Inc. shares jump on Middle East supply tensions; announces Transform to Outperform program targeting $2B EBITDAMixed▶
Dow Inc. shares jumped 2.57% on petrochemical supply shortages driven by Middle East tensions, with management announcing "Transform to Outperform" simplification program targeting at least $2 billion near-term operating EBITDA uplift. The plan includes $600-800 million severance for approximately 4,500 roles with phased rollout through 2028.
Apr 8Dow Inc. downgraded to Underperform by Bank of America amid petrochemical headwinds and oil price collapse.Negative▶
Bank of America downgraded Dow Inc. to Underperform on April 6. Stock declined 2% as oil prices tumbled following news of a US-Iran ceasefire. Company executing 4,500-job restructuring aimed at boosting profitability by $2B+. Earnings scheduled April 23.
Apr 7Dow Inc. faces Q2 EPS headwinds amid turnaround; earnings April 23; Fort Saskatchewan Path2Zero restart announcedMixed▶
Dow Inc. reported Q4 2025 EPS of -$0.34, beating estimates of -$0.49 by 30.61%. Company is set to report next earnings on April 23, 2026. Analysts forecast 1,700% drop in next-quarter EPS year-over-year amid challenged demand. Executing "Transform to Outperform" restructuring to reduce 4,500 roles (13% workforce) and pivot to high-margin, low-carbon products. Fort Saskatchewan Path2Zero project restart in early 2026 targets world's first net-zero integrated ethylene cracker. Long-term debt stands at $17.8B with 1.11 debt-to-equity ratio; dividend reset to $0.35/share (3.36% yield). Analyst consensus is Hold; Citigroup upgraded to Buy citing Strait of Hormuz constraints.
Apr 6Dow announces $2B restructuring program and benefits from petrochemical supply shortagesPositive▶
Dow announced "Transform to Outperform," a company-wide simplification program targeting at least $2 billion in near-term operating EBITDA uplift with $1.1-1.5 billion in one-time costs including $600-800 million severance for approximately 4,500 roles. Q4 2025 reported net loss of $0.34/share on sales of $9.5B (down 9% YoY), beating expectations. Citigroup upgraded DOW to buy citing export supply constraints as catalysts, with oil and natural gas spreads potentially widening. UBS raised price target to $40 from $37.
Apr 3Dow stock surges 75% YTD on Iran conflict supply shocks and $2B EBITDA restructuring plan; UBS raises target to $40.Positive▶
Dow Inc. has rallied 75% year-to-date driven by strategic restructuring targeting $2B in EBITDA gains and geopolitical supply shocks. The company announced 4,500 job cuts (13% of workforce) as part of Transform to Outperform initiative. UBS raised target to $40 from $37, while Citigroup upgraded to Buy from Neutral citing Iran war supply constraints.
Apr 2Dow Inc surges 75% YTD on $2B EBITDA uplift plan and Middle East supply shocks; stock up 2.57% amid Iran tensionsPositive▶
Dow Inc. has surged 75% year-to-date, driven by its "Transform to Outperform" productivity program targeting at least $2 billion in EBITDA uplift. The company announced $1.1-1.5 billion in one-time restructuring costs including $600-800 million severance for 4,500 roles, with $500M in-year savings for 2026. Stock up 2.57% amid petrochemical supply shortages from Iran conflict. Q4 reported loss of 34 cents per share on $9.5 billion revenue, beating expectations. Citigroup upgraded to Buy, citing supply constraints.
Sector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| DOWDOW | $40.39 | -0.25% | -0.2% | 19.6x | 0.49 | $29.2B |
| LINLINDE | $508.66 | +1.50% | +0.3% | 25.7x | 0.79 | $232.2B |
| NEMNEWMONT | $108.91 | -1.96% | -1.5% | 9.8x | 0.47 | $118.6B |
| FCXFREEPORT | $56.78 | -1.74% | -5.4% | 15.7x | 1.47 | $82.9B |
| SHWSHERWIN | $317.83 | -1.18% | +1.6% | 24.2x | 1.27 | $79.3B |
| CRHCRH | $115.72 | -2.28% | +11.4% | 18.0x | 1.24 | $79.1B |
Key Fundamentals
RSI (14-Day)
52-Week Range
Moving Averages
Price above both MAs — bullish structure.